A Polymorphism in MAPKAPK3 Affects Response to Interferon Therapy for Chronic Hepatitis C
Hironobu Tsukada(Sumitomo Dainippon Pharma (Japan)), Kazuaki Chayama(RIKEN Center for Integrative Medical Sciences), Hiromi Abe(Hiroshima University), Hiroshi Takahashi(RIKEN), Yoshifumi Fujimoto(Hiroshima University), T Maekawa(RIKEN Center for Integrative Medical Sciences), Naoyuki Kamatani, Yusuke Nakamura(Rissho University), Hiromitsu Kumada(Toranomon Hospital), Hidenori Ochi(Hiroshima University), Masataka Tsuge(Hiroshima University)
Cited by 42
Related Papers
Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
|New England Journal of Medicine|2008|1.3k
AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1
|Nature Genetics|2000|950
An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy
|Nature|1998|804